used in classic Chinese, Ayurvedic, and Thai drugs. Conolidine could signify the beginning of a completely new era of Continual agony management. It is now currently being investigated for its consequences around the atypical chemokine receptor (ACK3). In a rat product, it was identified that a competitor molecule binding to ACKR3 resulted in inhib